Abstract
Mixed mesodermal tumours (MMTs) are relatively rare gynaecological tumours that have been poorly studied in clinical and molecular terms. They are chemosensitive (at least initially), although ultimately they have a poor prognosis. The biology of the tumour is fascinating in view of its composition of both epithelial and mesenchymal entities. We review herein the literature on the clinical and biological aspects of this malignancy.
MeSH terms
-
Antineoplastic Agents / therapeutic use
-
Combined Modality Therapy / methods
-
Female
-
Genital Neoplasms, Female* / etiology
-
Genital Neoplasms, Female* / pathology
-
Genital Neoplasms, Female* / therapy
-
Humans
-
Mixed Tumor, Malignant* / etiology
-
Mixed Tumor, Malignant* / pathology
-
Mixed Tumor, Malignant* / therapy
-
Mixed Tumor, Mesodermal* / etiology
-
Mixed Tumor, Mesodermal* / pathology
-
Mixed Tumor, Mesodermal* / therapy
-
Prognosis